Felipe V. Gomes

Citado por

	Todos	Desde 2019
Citações	3981	2649
Índice h	34	30
Índice i10	54	46

560

280

140

420

2011201220132014201520162017201820192020202120222023202425 63 98 84 146 199 297 326 386 428 560 520 530 219

Acesso público

Ver todos

29 artigos

7 artigos

disponível

não disponível

Com base nas autorizações de financiamento

Coautores

Francisco Silveira GuimaraesAfiliação Department of Pharmacology, School of Medicine of Ribeirão Preto, USP, BrazilE-mail confirmado em fmrp.usp.br
Anthony A. Graceuniversity of pittsburghE-mail confirmado em pitt.edu
Leonardo Resstel Barbosa MoraesProfessor de Farmacologia, FMRP-USPE-mail confirmado em fmrp.usp.br
Fernando Morgan de Aguiar CorrêaProfessor of Pharmacology - School of Medicine of Ribeirão Preto - USPE-mail confirmado em fmrp.usp.br
Carlos Cesar CrestaniProfessor of Pharmacology, School of Pharmaceutical Sciences, São Paulo State University, UNESPE-mail confirmado em unesp.br
Sabrina F. LisboaResearch group leader, University of São Paulo, School of Pharmaceutical Sciences of Ribeirão PretoE-mail confirmado em usp.br
Samia R JocaProfessor de Farmacologia, FCFRP, Universidade de São PauloE-mail confirmado em usp.br
Plinio Cabrera CasarottoUniversity of HelsinkiE-mail confirmado em helsinki.fi
Raphael MechoulamProfessor of Medicinal Chemistry, Hebrew UniversityE-mail confirmado em cc.huji.ac.il
Daniele C AguiarProfessora de Farmacologia, Universidade Federal de Minas GeraisE-mail confirmado em ufmg.br
HOTT, SCE-mail confirmado em usp.br
MARIA-PAZ VIVEROSFull Professor Area Physiology, Complutense UniversityE-mail confirmado em ucm.es
Frederico Rogério FerreiraOswaldo Cruz Foundation - FIOCRUZ - IOCE-mail confirmado em ioc.fiocruz.br
Millie Rincón-Cortés, PhDDepartment of Neuroscience, School of Behavioral Brain Sciences, University of Texas at Dallas (UTD)E-mail confirmado em utdallas.edu
José Alexandre de Souza CrippaFaculdade de Medicina de Ribeirão PretoE-mail confirmado em fmrp.usp.br
James P HermanUniversity of CincinnatiE-mail confirmado em uc.edu
Ismael Galve-RoperhCIBERNED, Complutense University, IRYCISE-mail confirmado em quim.ucm.es
Ricardo LLorente MiguelUniversidad Complutense de MadridE-mail confirmado em ucm.es
MERITXELL LOPEZ GALLARDOProfessor of Physioloy (School of Medicine, Universidad Complutense de Madrid)E-mail confirmado em ucm.es
Antonio Waldo ZuardiProfessor, School of Medicine of Ribeirão Preto, University of São PauloE-mail confirmado em fmrp.usp.br

Seguir

Felipe V. Gomes

University of Sao Paulo

E-mail confirmado em usp.br


Título Ordenar por citações Ordenar por ano Ordenar por título	Citado por Citado por	Ano
Multiple mechanisms involved in the large-spectrum therapeutic potential of cannabidiol in psychiatric disorders AC Campos, FA Moreira, FV Gomes, EA Del Bel, FS Guimaraes Philosophical Transactions of the Royal Society B: Biological Sciences 367 …, 2012	518	2012
Mechanisms in the bed nucleus of the stria terminalis involved in control of autonomic and neuroendocrine functions: a review CC Crestani, FHF Alves, FV Gomes, L Resstel, F Correa, JP Herman Current neuropharmacology 11 (2), 141-159, 2013	280	2013
The anxiolytic-like effects of cannabidiol injected into the bed nucleus of the stria terminalis are mediated by 5-HT1A receptors FV Gomes, LBM Resstel, FS Guimarães Psychopharmacology 213, 465-473, 2011	204	2011
Plastic and neuroprotective mechanisms involved in the therapeutic effects of cannabidiol in psychiatric disorders AC Campos, MV Fogaça, FF Scarante, SRL Joca, AJ Sales, FV Gomes, ... Frontiers in pharmacology 8, 269, 2017	161	2017
Cannabidiol inhibitory effect on marble-burying behaviour: involvement of CB1 receptors PC Casarotto, FV Gomes, LBM Resstel, FS Guimarães Behavioural pharmacology 21 (4), 353-358, 2010	150	2010
Decreased glial reactivity could be involved in the antipsychotic-like effect of cannabidiol FV Gomes, R Llorente, EA Del Bel, MP Viveros, M López-Gallardo, ... Schizophrenia research 164 (1-3), 155-163, 2015	147	2015
The circuitry of dopamine system regulation and its disruption in schizophrenia: insights into treatment and prevention AA Grace, FV Gomes Schizophrenia bulletin 45 (1), 148-157, 2019	136	2019
Adolescence as a period of vulnerability and intervention in schizophrenia: Insights from the MAM model FV Gomes, M Rincón-Cortés, AA Grace Neuroscience & Biobehavioral Reviews 70, 260-270, 2016	122	2016
Cannabidiol injected into the bed nucleus of the stria terminalis reduces the expression of contextual fear conditioning via 5-HT_1A receptors FV Gomes, DG Reis, FHF Alves, FMA Corrêa, FS Guimaraes, ... Journal of psychopharmacology 26 (1), 104-113, 2012	106	2012
Fundamentos da psicofarmacologia FG Graeff, FS Guimarães, AC Campos, C Planeta, EA Del Bel, FA Moreira, ...	94	2021
Stress during critical periods of development and risk for schizophrenia FV Gomes, X Zhu, AA Grace Schizophrenia research 213, 107-113, 2019	90	2019
Dysregulation of midbrain dopamine system and the pathophysiology of schizophrenia SF Sonnenschein, FV Gomes, AA Grace Frontiers in psychiatry 11, 551915, 2020	89	2020
Cannabidiol attenuates sensorimotor gating disruption and molecular changes induced by chronic antagonism of NMDA receptors in mice FV Gomes, AC Issy, FR Ferreira, MP Viveros, EA Del Bel, FS Guimarães International Journal of Neuropsychopharmacology 18 (5), pyu041, 2015	85	2015
Effects of pubertal cannabinoid administration on attentional set-shifting and dopaminergic hyper-responsivity in a developmental disruption model of schizophrenia FV Gomes, FS Guimarães, AA Grace International Journal of Neuropsychopharmacology 18 (2), pyu018, 2015	83	2015
Cannabidiol attenuates catalepsy induced by distinct pharmacological mechanisms via 5-HT1A receptor activation in mice FV Gomes, EA Del Bel, FS Guimarães Progress in Neuro-Psychopharmacology and Biological Psychiatry 46, 43-47, 2013	81	2013
Prefrontal cortex dysfunction increases susceptibility to schizophrenia-like changes induced by adolescent stress exposure FV Gomes, AA Grace Schizophrenia bulletin 43 (3), 592-600, 2017	79	2017
Facilitation of CB1 receptor-mediated neurotransmission decreases marble burying behavior in mice FV Gomes, PC Casarotto, LBM Resstel, FS Guimarães Progress in Neuro-Psychopharmacology and Biological Psychiatry 35 (2), 434-438, 2011	77	2011
Cannabidiol effects in the prepulse inhibition disruption induced by amphetamine JFC Pedrazzi, AC Issy, FV Gomes, FS Guimarães, EA Del-Bel Psychopharmacology 232, 3057-3065, 2015	76	2015
The pathophysiological impact of stress on the dopamine system is dependent on the state of the critical period of vulnerability FV Gomes, X Zhu, AA Grace Molecular psychiatry 25 (12), 3278-3291, 2020	73	2020
Adolescent stress as a driving factor for schizophrenia development—a basic science perspective FV Gomes, AA Grace Schizophrenia bulletin 43 (3), 486-489, 2017	72	2017

O sistema não pode executar a operação agora. Tente novamente mais tarde.

Artigos 1–20

Citações por ano

Citações duplicadas

Citações mescladas

Adicionar coautoresCoautores

Seguir

Citado por

Coautores